
UnitedHealth Group (UNH) Stock Forecast & Price Target
UnitedHealth Group (UNH) Analyst Ratings
Bulls say
UnitedHealth Group is a global leader in providing medical insurance and healthcare services, with a strong presence in employer-sponsored, self-directed, and government-backed plans. With its massive scale and diversified offerings through its UnitedHealthcare and Optum segments, the company is well-positioned for long-term growth. Factors contributing to this positive outlook include solid financials, strong leadership, investments in emerging technologies, and strategic initiatives such as the recent sale of Optum UK and the acquisition of Alegeus Technologies. However, potential downside risks include Medicare reimbursement reductions and increased competition. With a strong start to 2026 and raised FY26 guidance, UNH's stock is expected to continue to perform well in the near future.
Bears say
UnitedHealth Group is facing risks from potential increases in commercial and Medicaid costs, regulatory scrutiny, and the year 3 phase-in of v28 risk model changes, leading to negative pressure on margins. The company’s investments in AI could potentially generate margin and growth benefits, but the majority of these effects will be weighted towards the end of 2026 and 2027. Additionally, there are risks associated with UnitedHealth Group's government exposure, continued care activity trends, regulatory changes, and competition.
This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.
UnitedHealth Group (UNH) Analyst Forecast & Price Prediction
Start investing in UnitedHealth Group (UNH)
Order type
Buy in
Order amount
Est. shares
0 shares